- Home
- ONEW vs ETON Comparison
ONEW vs ETON Comparison
Compare ONEW & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ONEW | ETON |
|---|---|---|
| Founded | 2014 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto & Home Supply Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.0M | 498.8M |
| IPO Year | 2020 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ONEW | ETON |
|---|---|---|
| Price | $10.36 | $16.43 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | $19.00 | ★ $29.67 |
| AVG Volume (30 Days) | 208.3K | ★ 269.3K |
| Earning Date | 01-29-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,872,334,000.00 | $70,316,000.00 |
| Revenue This Year | $2.33 | $113.27 |
| Revenue Next Year | $3.44 | $36.70 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 5.63 | ★ 102.77 |
| 52 Week Low | $10.28 | $11.09 |
| 52 Week High | $21.40 | $23.00 |
Technical Indicators
Market Signals| Indicator | ONEW | ETON |
|---|---|---|
| Relative Strength Index (RSI) | 31.34 | 47.89 |
| Support Level | $10.28 | $15.75 |
| Resistance Level | $10.81 | $17.19 |
| Average True Range (ATR) | 0.57 | 0.70 |
| MACD | -0.00 | 0.07 |
| Stochastic Oscillator | 1.23 | 58.47 |
Price Performance
Historical ComparisonAbout ONEW OneWater Marine Inc.
OneWater Marine Inc is a recreational marine retailer in the United States. The company operates in two segments: Dealership and Distribution. The Dealership segment is involved in selling new and pre-owned boats. It also arranges financing and insurance products, provides repairs and maintenance services, offers marine-related parts and accessories, and supplies slip and storage accommodations at certain locations. The Distribution segment focuses on the manufacturing, assembly, and distribution of marine-related products. These products are supplied to distributors, box retailers, and online retailers through a network of warehouses and distribution centers. The company generates the majority of its revenue from the Dealership segment.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.